- Home
- NEOV vs XBIT Comparison
NEOV vs XBIT Comparison
Compare NEOV & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEOV
- XBIT
- Stock Information
- Founded
- NEOV 2018
- XBIT 2005
- Country
- NEOV United States
- XBIT United States
- Employees
- NEOV N/A
- XBIT N/A
- Industry
- NEOV Industrial Machinery/Components
- XBIT Pharmaceuticals and Biotechnology
- Sector
- NEOV Miscellaneous
- XBIT Health Care
- Exchange
- NEOV Nasdaq
- XBIT Nasdaq
- Market Cap
- NEOV 153.9M
- XBIT 82.3M
- IPO Year
- NEOV N/A
- XBIT 2015
- Fundamental
- Price
- NEOV $5.51
- XBIT $2.51
- Analyst Decision
- NEOV Hold
- XBIT
- Analyst Count
- NEOV 1
- XBIT 0
- Target Price
- NEOV N/A
- XBIT N/A
- AVG Volume (30 Days)
- NEOV 361.5K
- XBIT 69.3K
- Earning Date
- NEOV 11-07-2025
- XBIT 11-12-2025
- Dividend Yield
- NEOV N/A
- XBIT N/A
- EPS Growth
- NEOV N/A
- XBIT N/A
- EPS
- NEOV N/A
- XBIT N/A
- Revenue
- NEOV $8,426,835.00
- XBIT N/A
- Revenue This Year
- NEOV $91.25
- XBIT N/A
- Revenue Next Year
- NEOV $30.38
- XBIT N/A
- P/E Ratio
- NEOV N/A
- XBIT N/A
- Revenue Growth
- NEOV 218.59
- XBIT N/A
- 52 Week Low
- NEOV $1.80
- XBIT $2.35
- 52 Week High
- NEOV $6.19
- XBIT $8.32
- Technical
- Relative Strength Index (RSI)
- NEOV 57.81
- XBIT 35.16
- Support Level
- NEOV $5.30
- XBIT $2.52
- Resistance Level
- NEOV $6.19
- XBIT $2.73
- Average True Range (ATR)
- NEOV 0.50
- XBIT 0.09
- MACD
- NEOV 0.02
- XBIT -0.00
- Stochastic Oscillator
- NEOV 66.43
- XBIT 35.42
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.